A new member of the Audit Committee of Latvenergo AS has been approved
February 3, 2021
On February 3, the Shareholders’ Meeting of Latvenergo AS approved Ilvija Grūba as a new member of the Audit Committee of Latvenergo AS.
On February 3, the Shareholders' Meeting of Latvenergo AS decided to approve four existing members of the Audit Committee - Torben Pedersen (independent committee member), Svens Dinsdorfs (independent committee member), Toms Siliņš (member of the Supervisory Board of Latvenergo AS), Gundars Ruža (member of the Supervisory Board of Latvenergo AS), as well as one new member of the committee Ilvija Grūba (independent committee member) in the Audit Committee of Latvenergo AS for a term of three years from 3 February 2021.
Ilvija Grūba has extensive experience in compliance control, as she has held different positions in AstraZeneca, an international company, since 2012. I.Grūba has led global scale compliance projects, participated in and supervised the establishment of internal audit and compliance control systems, supervised data protection, led anti-corruption trainings and had experience as the chairperson of an audit committee. Currently, I.Grūba is a Compliance Assurance Lead at AstraZeneca and supervises Europe, Canada, Russia and Eurasia. I.Grūba has a Master degree in Social Sciences in Management from the University of Latvia, and a certificate of a Certified Internal Auditor (CIA) from the Institute of Internal Auditors (United States).
The new member of the Audit Committee has been selected through a competition. The changes to the Audit Committee are related to the resignation letter submitted by the former committee member Marita Salgrāve at the end of last year.